Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History CPIX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics CPIX

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Cumberland Pharmaceuticals Inc

CPIX
Current price
3.04 USD -0.17 USD (-5.30%)
Last closed 3.15 USD
ISIN US2307701092
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 47 127 468 USD
Yield for 12 month +104.03 %
1Y
3Y
5Y
10Y
15Y
CPIX
21.11.2021 - 28.11.2021

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Sancuso, an injection for the prevention of nausea and vomiting for patients receiving chemotherapy treatment; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; and Vibativ, an injection for the treatment of certain bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It also develops ifetroban, a product candidate that has completed Phase II clinical trials for the treatment of the cardiomyopathy associate with Duchenne muscular dystrophy, hepatorenal syndrome, portal hypertension, and aspirin-exacerbated respiratory disease; and is in Phase II clinical trial for the treatment of systemic sclerosis and idiopathic pulmonary fibrosis. Cumberland Pharmaceuticals Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee. Address: 1600 West End Avenue, Nashville, TN, United States, 37203

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

8.50 USD

P/E Ratio

Dividend Yield

Financials CPIX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures CPIX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+37 867 945 USD

Last Year

+39 552 507 USD

Current Quarter

+11 713 055 USD

Last Quarter

+10 435 569 USD

Current Year

+26 379 413 USD

Last Year

+33 485 896 USD

Current Quarter

+10 287 341 USD

Last Quarter

+6 962 702 USD
EBITDA 1 512 247 USD
Operating Margin TTM 11.03 %
Price to Earnings
Return On Assets TTM -2.70 %
PEG Ratio
Return On Equity TTM -11.86 %
Wall Street Target Price 8.50 USD
Revenue TTM 41 083 300 USD
Book Value 1.92 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 37.80 %
Dividend Yield
Gross Profit TTM 34 647 156 USD
Earnings per share -0.24 USD
Diluted Eps TTM -0.24 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin -7.98 %

Stock Valuation CPIX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1.13
Price Sales TTM 1.15
Enterprise Value EBITDA 14.25
Price Book MRQ 1.78

Technical Indicators CPIX

For 52 Weeks

1.04 USD 7.25 USD
50 Day MA 4.79 USD
Shares Short Prior Month 62 724
200 Day MA 3.30 USD
Short Ratio 1.71
Shares Short 68 133
Short Percent 0.78 %